Loading
Life sciences · Journal article
Nano · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Breast cancer is a highly prevalent malignancy worldwide. Current clinical treatments including surgery, chemotherapy and phototherapy still suffer from inevitable limitations, such as invasive trauma, systemic side effects, drug resistance and insufficient immune activation, which restrict further therapeutic improvement. To address these drawbacks, an injectable chitosan/hyaluronic acid/barium titanate (CS/HA/BTO) composite hydrogel was fabricated in this work for ultrasound-controlled piezocatalytic breast tumor therapy. The CS/HA hydrogel matrix exhibits excellent adhesion, self-healing performance and shear-thinning injectability, and achieves pH-responsive sustained release of BTO nanoparticles. After systematic screening, 200 μg/mL was confirmed as the optimal and biosafe working concentration. In vitro cellular experiments demonstrated that ultrasonic excitation enables BTO to generate abundant reactive oxygen species via piezocatalysis, which efficiently kills MCF-7 breast cancer cells. Moreover, piezocatalytic stimulation induced distinct expression changes among TIPE genes associated with tumor apoptosis regulation. Different from conventional tumor treatment modes, this ultrasound-responsive piezocatalytic hydrogel avoids drug-related toxicity, providing a promising in-vitro therapeutic platform for localized breast cancer targeted therapy.